Coherus' new focus on oncology leads to restructuring, 30% layoffs
Coherus BioSciences is laying off about 30% of its staff by the end of the year, following its plan to focus on oncology and its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
